SLNCF 8-K 2026-06-23

Silence Therapeutics plc (SLNCF) 8-K dated 2026-06-23 — accession 0001193125-26-279577.

Silence Therapeutics plc (SLNCF) is a biotechnology company listed on US.

Silence Therapeutics plc filed a 8-K on 2026-06-23. Accession 0001193125-26-279577.

This 8-K covers: Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for SLNCF is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The SLNCF SEC hub lists recent forms. The stock page is the research view.